FACS analyses revealed that U266 cells express the highest levels of syndecan-1 (Figure 2C, upper panel), as would be expected for myeloma cells, whereas U87 cells express high levels of syndecan-4 (Figure 2C, lower panel). This evidence concerns the gene SDC1 and plasma cell myeloma.